Everything on Business Model Risk

The withdrawal of Hims and Hers' compounded Weigovi plan signals a broader shift in how telehealth companies navigate regulatory boundaries. It highlights the fragility of business models reliant on compounding loopholes.

Impact: Telehealth firms may need to diversify their product offerings or seek direct partnerships with manufacturers to mitigate regulatory risk.

— from GLP-1 Pricing Pressure and UK Political Risk · WSJ What’s News· Feb 09, 2026